BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Li X, Xia Y, Chu Y, Zhong H, Li J, Liang P, Bu Y, Zhao R, Liao Y, Yang P, Lu X, Jiang S. Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy. Front Pharmacol 2020;11:786. [PMID: 32547394 DOI: 10.3389/fphar.2020.00786] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Gatti M, Pea F. Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors. Expert Rev Clin Pharmacol 2021;14:583-99. [PMID: 33687300 DOI: 10.1080/17512433.2021.1901574] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Shi L, Zhuang Z, Duan L, Zhu C, Xue H, Wang X, Xu X, Yuan Y, Shi L, Li J, Sun J, Liu X, Zhou Q, Lu J, Tang L. Dose Optimization of Teicoplanin for Critically Ill Patients With Renal Dysfunction and Continuous Renal Replacement Therapy: Experience From a Prospective Interventional Study. Front Pharmacol 2022;13:817401. [PMID: 35350761 DOI: 10.3389/fphar.2022.817401] [Reference Citation Analysis]
3 Song H, Yuan Z, Peng Y, Luo G. Extracorporeal membrane oxygenation combined with continuous renal replacement therapy for the treatment of severe burns: current status and challenges. Burns Trauma 2021;9:tkab017. [PMID: 34212063 DOI: 10.1093/burnst/tkab017] [Reference Citation Analysis]
4 Wahby KA, Cunmuljaj L, Mouabbi K, Almadrahi Z, Wilpula L. Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration. Pharmacotherapy 2021;41:554-61. [PMID: 33963536 DOI: 10.1002/phar.2535] [Reference Citation Analysis]
5 Li DY, Li L, Li GZ, Hu YH, Guo HL, Jing X, Chen F, Ji X, Xu J, Dai HR. Population Pharmacokinetics Modeling of Vancomycin Among Chinese Infants With Normal and Augmented Renal Function. Front Pediatr 2021;9:713588. [PMID: 34616698 DOI: 10.3389/fped.2021.713588] [Reference Citation Analysis]
6 Chen J, Li S, Wang Q, Wang C, Qiu Y, Yang L, Han R, Du Q, Chen L, Dong Y, Wang T. Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy. Pharmaceutics 2022;14:842. [DOI: 10.3390/pharmaceutics14040842] [Reference Citation Analysis]
7 Hashimoto M, Asai S, Umezawa K, Kohara K, Miyazawa M, Suzuki Y, Miyachi H. Impact of ward pharmacist-led antimicrobial stewardship in intensive care units. J Chemother 2022;:1-10. [PMID: 35748502 DOI: 10.1080/1120009X.2022.2087652] [Reference Citation Analysis]
8 Gorham J, Taccone FS, Hites M. Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review. Antibiotics 2022;11:546. [DOI: 10.3390/antibiotics11050546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Al-Shaer MH, Philpott CD, Droege CA, Courter JD, Healy DP, Droege ME, Ernst NE, Mueller EW, Peloquin CA. Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy. Antimicrob Agents Chemother 2021;65:e00144-21. [PMID: 33722885 DOI: 10.1128/AAC.00144-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen J, Huang X, Lin Z, Li C, Ding H, Du J, Li L. Case Report: Monitoring Vancomycin Concentrations and Pharmacokinetic Parameters in Continuous Veno-Venous Hemofiltration Patients to Guide Individualized Dosage Regimens: A Case Analysis. Front Pharmacol 2021;12:763575. [PMID: 34955835 DOI: 10.3389/fphar.2021.763575] [Reference Citation Analysis]
11 Yang N, Wang J, Xie Y, Ding J, Wu C, Liu J, Pei Q. External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients. Front Pharmacol 2022;13:838205. [PMID: 35662716 DOI: 10.3389/fphar.2022.838205] [Reference Citation Analysis]
12 Ylipalosaari P, Ala-Kokko TI, Koskenkari J, Laurila JJ, Ämmälä S, Syrjälä H. Use and outcome of empiric echinocandins in critically ill patients. Acta Anaesthesiol Scand 2021;65:944-51. [PMID: 33481252 DOI: 10.1111/aas.13783] [Reference Citation Analysis]
13 Zheng G, Zhang J, Wang B, Cai J, Wang L, Hou K, Zhang Y, Zhang L, Yang Z, He J, Bian X. Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study. Infect Dis Ther 2021;10:1699-713. [PMID: 34241831 DOI: 10.1007/s40121-021-00479-7] [Reference Citation Analysis]
14 Huang X, Yu Z, Wei X, Shi J, Wang Y, Wang Z, Chen J, Bu S, Li L, Gao F, Zhang J, Xu A. Prediction of vancomycin dose on high-dimensional data using machine learning techniques. Expert Rev Clin Pharmacol 2021;14:761-71. [PMID: 33835879 DOI: 10.1080/17512433.2021.1911642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Wang C, Zhang C, Li X, Zhao S, He N, Zhai S, Ge Q. Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis. Antibiotics (Basel) 2021;10:1392. [PMID: 34827330 DOI: 10.3390/antibiotics10111392] [Reference Citation Analysis]
16 Gatti M, Pea F. Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics. Clin Pharmacokinet 2021. [PMID: 34125420 DOI: 10.1007/s40262-021-01040-y] [Reference Citation Analysis]
17 Bitterman R, Koppel F, Mussini C, Geffen Y, Chowers M, Rahav G, Nesher L, Ben-Ami R, Turjeman A, Huberman Samuel M, Cheng MP, Lee TC, Leibovici L, Yahav D, Paul M. Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen). BMJ Open 2021;11:e040210. [PMID: 33558347 DOI: 10.1136/bmjopen-2020-040210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Matusik E. Commentary: Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy. Front Pharmacol 2020;11:580163. [PMID: 33041825 DOI: 10.3389/fphar.2020.580163] [Reference Citation Analysis]
19 Xu C, Liu X, Cui Y, Huang X, Wang Y, Fan Y, Wu H, Li X, Guo B, Zhang J, Zhang Y. Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance. Front Pharmacol 2022;13:822981. [DOI: 10.3389/fphar.2022.822981] [Reference Citation Analysis]
20 Bouajram RH, Awdishu L. A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy. Kidney Int Rep 2021;6:2033-48. [PMID: 34386653 DOI: 10.1016/j.ekir.2021.05.004] [Reference Citation Analysis]
21 Xu E, Pérez-Torres D, Fragkou PC, Zahar JR, Koulenti D. Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management. Microorganisms 2021;9:534. [PMID: 33807623 DOI: 10.3390/microorganisms9030534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Baud FJ, Seif V, Houzé P, Raphalen JH, Pilmis B, Carli P, Lamhaut L. Elimination of three doses of gentamicin over three consecutive days using a polyacrylonitrile-derived filter: An in vitro assessment. Int J Artif Organs 2021;:3913988211032236. [PMID: 34348515 DOI: 10.1177/03913988211032236] [Reference Citation Analysis]
23 Zimmer J, Röhr AC, Kluge S, Faller J, Frey OR, Wichmann D, König C. Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol. Antibiotics (Basel) 2021;10:242. [PMID: 33670891 DOI: 10.3390/antibiotics10030242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]